Topiramate
Treatment for Idiopathic epilepsy
Typical Dosage: 100-400 mg daily
Effectiveness
75%
Safety Score
55%
Clinical Trials
1
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
100-400 mg daily
Time to Effect
Weeks to months
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$800
Monitoring:$450
Side Effect Mgmt:$300
Total Annual:$1,550
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$17,222/QALY
QALYs Gained
4.5
Outcome-Based Costs
Cost per Responder
$3,444
Cost per Remission
$4,429
Topiramate Outcomes
for Idiopathic epilepsy
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Topiramate in Idiopathic epilepsy
Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients
NCT00236886COMPLETEDPHASE3
49 participants
INTERVENTIONAL
Started: May 1, 1998